Vical, Inc. (NASDAQ:VICL)

colbob2 (< 20) Submitted: 12/3/2009 5:22:50 PM : Start Price: $2.90 VICL Score: -19.84

AS A PHARMACIST I FEEL THE FUTURE IN DRUGS IS IN THE VACINE FIELD, WHICH VICL EXCELS. WITH MONEY FROM MERCK, AND SNY. I FEEL THAT THIS STOCK WILL MOVE UP NEXT YEAR AND FEEL THAT THE SELL OFF THAT IS NOW GOING ON IS A TAX RELIEF SELL OFF.

crichton1 (< 20) Submitted: 10/8/2009 8:52:37 PM : Start Price: $3.86 VICL Score: -50.04

Good entry point for medical products approved next year.

KnowWhen2Holdem (26.42) Submitted: 7/6/2008 6:42:06 PM : Start Price: $3.52 VICL Score: -26.52

DNA plasmid technology for pandemic flu (results out in 8/08), peripheral artery disease partnered with ANGES (already approved in Japan) and SNY, Melanoma, CMV, etc. Other iron in fire is Vaxfectin as adjuvant for vaccines. Stock has gone from fantasy land pricing to reality. No current interest with slowly increasing volume and price. Very low capitalization (approximately 140 mm). This is one of those risky biotechs with big up and downside.

ipericles (51.16) Submitted: 3/13/2008 7:41:51 PM : Start Price: $3.34 VICL Score: -18.36

Company has innovative technologies that will make certain remedies (vaccines and the like) more effective in their intended use.

EtownDunk (29.99) Submitted: 10/27/2007 1:03:09 AM : Start Price: $5.19 VICL Score: -35.00

Nice Cash Flow Growth (TTM vs Prior), Good Oper Margin (TTM vs. 5yr) and relatively low Price/Book

tharlow (31.04) Submitted: 8/22/2007 3:28:35 AM : Start Price: $4.82 VICL Score: -36.11

Science will prevail.

moorefish (< 20) Submitted: 11/19/2006 7:02:32 AM : Start Price: $6.43 VICL Score: -55.78

Out of fashion, but possibly amazing jabs on the way

deugei1 (47.28) Submitted: 10/22/2006 1:01:56 AM : Start Price: $5.93 VICL Score: -54.61

Great test results, and it's flu season.